— Research Peptide

Semax 5 MG

$30.00 CAD · per vial

For in-vitro laboratory research use only
Committed to ≥99% HPLCThird-Party TestingHeavy-Metal ScreeningShips from CanadaResearch Account

Research account required · Apply here →

Secure checkoutShips from CanadaRUO compliance
SKU: BQE7CKW5NCategory:

Description

Research Peptide≥99% HPLC StandardShips from Canada

01 — Product Overview

Overview

Semax is a synthetic heptapeptide analog of the ACTH(4-10) fragment of adrenocorticotropic hormone, modified so that it lacks hormonal (corticotropic) activity while retaining effects on the nervous system. It is supplied as a stable lyophilized peptide.

In research it is studied as a neuroactive and neuroprotective peptide, with a focus on brain-derived neurotrophic factor (BDNF) signalling, cognition, and responses to neural stress. It is offered strictly as a research material, and the study cited below describes preclinical findings only.

02 — Mechanisms of Interest

Mechanisms of interest in research

BDNF and trkB signalling

Preclinical / in-vitro

A central research finding for Semax is its effect on brain-derived neurotrophic factor and its receptor trkB, a pathway supporting neuronal survival and plasticity. Elevated BDNF/trkB signalling is associated with the cognitive and neuroprotective endpoints studied.

Neuroprotection and neuroplasticity models

Preclinical / in-vitro

Semax is examined in models of ischaemia and cognitive challenge for protective and plasticity-promoting effects, consistent with its neurotrophic actions.

Monoaminergic and melanocortin heritage

Preclinical / in-vitro

As an ACTH-fragment analog stripped of hormonal activity, Semax is also studied for effects on monoaminergic systems and attention, part of its broad neuroactive profile.

03 — Specifications

Specifications

CAS Number80714-61-0
Molecular FormulaC37H51N9O10S
Molar Mass813.93 g/mol
Vial Contents5 MG lyophilized peptide
StorageStable at room temperature prior to reconstitution; once reconstituted, store at 2–8°C
TestingThird-party testing including heavy metal screening
04 — Selected Research

Selected Research

The following peer-reviewed studies are provided for scientific context on this compound’s research background. They describe preclinical and in-vitro findings only and are not claims about this product.

A single intranasal dose of Semax increased hippocampal BDNF protein about 1.4-fold and trkB phosphorylation about 1.6-fold, accompanied by improved cognitive performance in rats.
Dolotov OV, et al. Brain Res. PMID: 16996037

In a rat model of permanent middle-cerebral-artery occlusion, Semax predominantly enhanced expression of immune- and vascular-system genes in ischaemic brain tissue, consistent with a neuroprotective mechanism.
Medvedeva EV, et al. BMC Genomics. PMID: 24661604

05 — Research Use Only

This product is intended exclusively for in-vitro laboratory research. It is not a drug, food, dietary supplement, or cosmetic, and it is not intended for human or veterinary diagnostic, therapeutic, or recreational use.

By purchasing, you certify that you are a qualified researcher acquiring this material strictly for legitimate scientific purposes.
No researcher feedback yet.Verified researchers can share observations once they have received this compound.
$30.00 CAD